[Lancet Respir Med发表论文]:前瞻性评价TREM-1抑制剂nangibotide对感染性休克患者的疗效、安全性及生物标志物富集策略已关闭评论
ARTICLES|ONLINE FIRST
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial
Bruno François, Simon Lambden, Tom Fivez, et al.
Lancet Respir Med Published:May 31, 2023
DOI:https://doi.org/10.1016/S2213-2600(23)00158-3
Summary
Background
Activation of the triggering receptor expressed on...
阅读全文
[Lancet Respir Med发表论文]:以色列ICU中重症新冠肺炎孕妇和产妇的预后预测因素及疾病进展已关闭评论
ARTICLES| VOLUME 11, ISSUE 6, P520-529, JUNE 2023
Outcome predictors and patient progress following delivery in pregnant and postpartum patients with severe COVID-19 pneumonitis in intensive care units in Israel (OB-COVICU): a nationwide cohort study
Elena Fatnic, Nikole Lee Blanco, Roman Cobiletchi, et al.
Lancet Respir Med 2023; 11: 520-529
DOI:https://doi.org/10.1016/S2213-2600(22)00491-X
Summary
Background
A key unresolved controver...
阅读全文
[Lancet Microbe发表论文]:西班牙入住ICU的重症新冠病毒感染患者病毒风暴的影响已关闭评论
ARTICLES| VOLUME 4, ISSUE 6, E431-E441, JUNE 2023
Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study
Jesús F Bermejo-Martin, Nadia García-Mateo, Anna Motos, et al.
Lancet Microbe 2023; 4: E431-E441
DOI:https://doi.org/10.1016/S2666-5247(23)00041-1
Summary
Background
The contribution of the virus to the pathogenesis of severe COVID-19 is still unclear...
阅读全文
[BMJ发表述评]:了解新冠病毒感染后的疾病负担已关闭评论
Editorials
Understanding the burden of post-covid-19 condition
Qiao Wu
BMJ 2023; 381 doi: https://doi.org/10.1136/bmj.p932 (Published 31 May 2023)Cite this as: BMJ 2023;381:p932
A complex picture is emerging, along with urgent priorities for future research
Covid-19 cases and deaths have decreased globally,1 yet, the long term consequences of infection, including post-covid-19 condition (often known as long covid), are still being managed. Most people ...
阅读全文
[JAMA发表述评]:与重症住院患者讨论治疗目标已关闭评论
Editorial
May 21, 2023
Conversations on Goals of Care With Hospitalized, Seriously Ill Patients
Douglas B. White, Sarah K. Andersen
JAMA. Published online May 21, 2023. doi:10.1001/jama.2023.8970
Goals-of-care conversations between clinicians and patients with serious illness have been shown to improve measures of patient and family well-being, while also decreasing health care costs and high-intensity treatments at the end of life.1,2 ...
阅读全文
[Lancet Microbe发表论文]:香港接种新冠病毒灭活疫苗或mRNA疫苗的成年人针对奥密克戎BA.1的特异性T细胞反应已关闭评论
ARTICLES| VOLUME 4, ISSUE 6, E418-E430, JUNE 2023
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study
Chris Ka Pun Mok, Chunke Chen, Shilin Zhao, et al.
Lancet Microbe 2023; 4: E418-E430
DOI:https://doi.org/10.1016/S2666-5247(23)00006-X
Summary
Background
The primary aim of using vaccines in public health responses to SARS-CoV-2 variants of concern is to redu...
阅读全文
[NEJM发表论文]:采用视频喉镜进行气管插管—采取新范式的时机来临?已关闭评论
EDITORIAL
Video Laryngoscopy for Intubation — Time for a New Paradigm?
Yonathan Freund, Ben Bloom
N Engl J Med June 16, 2023DOI: 10.1056/NEJMe2305596
Endotracheal intubation — a potentially lifesaving procedure that is used for the care of many critically ill patients — demands precision, speed, and skill. It involves the placement of a tube into the trachea to protect the airways while ensuring adequate oxygenation and ventilation for patients who are in resp...
阅读全文
[Lancet Microbe发表论文]:新冠病毒不同变异株、个体因素及感染患者对潜伏期的影像已关闭评论
ARTICLES| VOLUME 4, ISSUE 6, E409-E417, JUNE 2023
SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study
Simon Galmiche, Thomas Cortier, Tiffany Charmet, et al.
Lancet Microbe 2023; 6: E409-E417
DOI:https://doi.org/10.1016/S2666-5247(23)00005-8
Summary
Background
The incubation period of SARS-CoV-2 has been estimated for the know...
阅读全文
[NEJM发表述评]:麻风暴露后预防的新进步已关闭评论
EDITORIAL
A New Step in Postexposure Prophylaxis for Leprosy
David M. Scollard
N Engl J Med 2023; 388:1904-1905DOI: 10.1056/NEJMe2302667
Infection with Mycobacterium leprae is curable with a combination of dapsone, rifampin, and clofazimine (multidrug therapy), as recommended by the World Health Organization (WHO) in 1982. The use of this multidrug regimen led to an initial rapid decline in the global prevalence of M. leprae infection, a re...
阅读全文
[Lancet Microbe发表论文]:新冠病毒家庭传播的危险因素与载体已关闭评论
ARTICLES| VOLUME 4, ISSUE 6, E397-E408, JUNE 2023
Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort study
Nieves Derqui, Aleksandra Koycheva, Jie Zhou, et al
Lancet Microbe 2023; 4: E397-E408
DOI:https://doi.org/10.1016/S2666-5247(23)00069-1
Summary
Background
Despite circumstantial evidence for aerosol and fomite spread of SARS-CoV-2, empirical data linking either pathway with transmissi...
阅读全文